Liquidia Corporation ( LQDA) - Key Metrics
LQDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.93 | $0.84 | $0.90 | $0.78 |
| 2026Q1 | $1.51 | $0.60 | -$0.41 | -$0.45 |
| 2025Q4 | $1.06 | $0.17 | $0.51 | $0.48 |
| 2025Q3 | $0.63 | -$0.04 | -$0.11 | -$0.12 |
| 2025Q2 | $0.10 | -$0.49 | -$0.46 | -$0.47 |
LQDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 23.73 |
| 2026Q1 | 0% | 15.73 |
| 2025Q4 | 0% | 50.72 |
| 2025Q3 | 0% | -139.00 |
| 2025Q2 | 0% | -6.36 |
LQDA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.97% | 0% |
| 2026Q1 | -1.20% | 0% |
| 2025Q4 | 1.40% | 0% |
| 2025Q3 | -0.54% | 0% |
| 2025Q2 | -3.80% | 0% |
LQDA
Price: $74.44
52 week price:
Earnings Per Share: 1.40 USD
P/E Ratio: 53.17
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65756
Market Capitalization: 6.7 billion